Skip to main content
. 2015 Dec 30;594(3):567–593. doi: 10.1113/JP271282

Figure 14. Experimental test of predicted polytherapy .

Figure 14

A and B, representative tracings from WT and R176Q/+ mice are shown at baseline and after sympathetic challenge with no drug (A) and following administration of flecainide, metoprolol and KN‐93 (B). C, summary of data without (left) and following (right) pre‐treatment with flecainide, metoprolol and KN‐93, which suppressed VT in all R176Q/+ mice (*P = 0.015).